Jenny Zhang is a senior associate in Goodwin’s Intellectual Property Litigation practice and is a member of the firm’s Life Sciences Disputes group. She focuses her practice on patent litigation across a wide range of technologies and advises clients in developing and executing litigation strategy across multiple forums. In 2020, Ms. Zhang returned to Goodwin from a clerkship at the U.S. Court of Appeals for the Federal Circuit. She maintains an active pro bono practice.





Ms. Zhang has extensive experience representing both patentees and patent challengers in all phases of litigation. Past matters include representing:

  • A global healthcare company in ITC investigation and related district court litigation over pre-filled syringe technology for intravitreal injection;
  • Teva in Hatch-Waxman litigation related to a generic version of a drug product for the treatment of ADHD;
  • E. & J. Gallo Winery in patent litigation related to variable rate irrigation technology;
  • A small technology company in theft of trade secret litigation in California state court against a former employee.
  • Fresenius Kabi in inter partes review proceedings involving patents on purification processes for proteins expressed in non-mammalian systems;
  • Celltrion in parallel BPCIA patent infringement and inter partes review proceedings involving Celltrion’s proposed biosimilar to the oncology drug, Herceptin® (trastuzumab);
  • Actavis at trial over patents in the District of New Jersey related to an oral solid dosage form of the opioid receptor antagonist drug, Relistor® (methylnaltrexone);
  • Actavis in Hatch-Waxman litigation brought by AstraZeneca in the District of Delaware involving the cardiovascular drug, Brilinta® (ticagrelor);
  • Teva at trial in litigation against five generic manufacturers involving patents directed to the treatment of multiple sclerosis with a new dosing regimen for Copaxone® (glatiramer acetate);
  • West-Ward Pharmaceuticals in litigation brought by Hospira in the District of Delaware related to the sedative drug, Precedex® (dexmedetomidine);
  • Multiple biologic and biosimilar manufacturers in various non-public representations, including pre-suit investigations and arbitration proceedings;
  • A startup founder in proceedings to remove state court dispute to federal court by asserting patent counterclaims related to rights over metal alloy technology;
  • A small business patentee in litigation in the Eastern District of Texas over digital rights management technology; 


Ms. Zhang maintains an active pro bono practice, representing individual and organization clients in both civil and criminal proceedings on a wide range of issues. Her practice has included:

  • Successfully challenging, on First Amendment grounds, an anti-panhandling ordinance enacted by the City of Lowell, MA on behalf of homeless residents, McLaughlin v. City of Lowell (D. Mass.);
  • Winning a preliminary injunction, on Eighth Amendment and ADA grounds, against a prison’s denial of methadone treatment to an inmate recovering from opioid use disorder, Pesce v. Coppinger (D. Mass.); Preparing a trial defense for indigent former healthcare insurance executive facing multiple federal healthcare fraud and identity theft charges, U.S. v. Brettschneider (D. Mass.);
  • Co-authoring a cert-stage amicus brief on behalf of CATO Institute and Florida Association of Criminal Defense Lawyers challenging the Eleventh Circuit’s interpretation of the harmless-error standard in criminal cases, Pon v. United States;
  • Co-authoring a cert-stage amicus brief on behalf of coalition of minority veterans organizations challenging the constitutionality of sex-based Selective Service registration requirement, National Coalition for Men v. Selective Service System;
  • Co-authoring petition for rehearing en banc on Fourth Amendment inevitable discovery doctrine in criminal appeal, U.S. v. Raymond Bullette (4th Cir.);
  • Co-authoring amicus brief on behalf of National Women’s Law Center defending constitutionality of the Affordable Care Act, Texas v. United States (5th Cir.);
  • Co-authoring amicus brief on behalf of World Professional Association for Transgender Health challenging constitutionality of North Carolina’s public restrooms law, Carcano v. Cooper (4th Cir.).

Professional Experience

Ms. Zhang joined Goodwin in 2013. In 2017-2018, she clerked for the Honorable Cynthia M. Rufe at the U.S. District Court for the Eastern District of Pennsylvania, and in 2019-2020, she clerked for the Honorable Jimmie V. Reyna at the U.S. Court of Appeals for the Federal Circuit.

While attending law school, Ms. Zhang served as a judicial intern to the Honorable John G. Koeltl of the Southern District of New York and the Honorable Robert A. Katzmann of the Second Circuit Court of Appeals. She also served as a summer legal intern with the United States Army Judge Advocate General’s Corps at Fort Bragg, North Carolina. Ms. Zhang served as a teaching assistant for Torts and Contracts and as an Articles Editor for the Columbia Journal of Gender and Law.

Professional Activities
Ms. Zhang serves as a Vice-Chair of the Amicus Committee of the Federal Circuit Bar Association. She will also serve as a co-lead of the Administrative Committee of the Giles S. Rich Inn of Court beginning in Fall 2022. 

In The News









J.D., 2013
Columbia Law School
(Harlan Fiske Stone Scholar)
A.B., 2010
Harvard University
(cum laude)


2019-2020 Federal Circuit Court of Appeals, Jimmie V. Reyna
2017-2018 U.S. District Court for the Eastern District of Pennsylvania, Honorable Cynthia M. Rufe



New York
District of Columbia
U.S. Patent and Trademark Office (USPTO)


U.S. Court of Appeals for the Federal Circuit
U.S. Court of Appeals for the Fourth Circuit
U.S. District Court for the District of Massachusetts
U.S. District Court for the Eastern District of California
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique